Answer
Circadin (melatonin) is licensed as monotherapy for the short-term treatment of primary insomnia characterised by poor quality of sleep in adults aged 55 or over.
Sources for this answer
- CircadinFlynn Pharma Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 12Document updated
Sources checked